PROK ProKidney Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PROK

Price (delayed)

$2.2

Market cap

$504.56M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.57

Enterprise value

$448.32M

Highlights
The net income has surged by 67% year-on-year and by 2.2% since the previous quarter
The EPS has dropped by 148% year-on-year
ProKidney's debt has soared by 84% YoY and by 58% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of PROK
Market
Shares outstanding
229.34M
Market cap
$504.56M
Enterprise value
$448.32M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$29.46M
EBITDA
-$25.61M
Free cash flow
-$124.27M
Per share
EPS
-$0.57
Free cash flow per share
-$2.01
Book value per share
-$4.69
Revenue per share
$0
TBVPS
$6.81
Balance sheet
Total assets
$420.55M
Total liabilities
$29.22M
Debt
$4.41M
Equity
-$1.1B
Working capital
$349.11M
Liquidity
Debt to equity
0
Current ratio
14.94
Quick ratio
14.5
Net debt/EBITDA
2.2
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-7.7%
Return on equity
N/A
Return on invested capital
-11.6%
Return on capital employed
-7.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PROK stock price

How has the ProKidney stock price performed over time
Intraday
2.33%
1 week
3.77%
1 month
47.65%
1 year
-76.5%
YTD
23.6%
QTD
34.15%

Financial performance

How have ProKidney's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$151.52M
Net income
-$35.47M
Gross margin
N/A
Net margin
N/A
The net income has surged by 67% year-on-year and by 2.2% since the previous quarter
ProKidney's operating income has increased by 3.8% from the previous quarter

Growth

What is ProKidney's growth rate over time

Valuation

What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 148% year-on-year

Efficiency

How efficient is ProKidney business performance
The return on invested capital has surged by 92% year-on-year and by 41% since the previous quarter
The return on assets has surged by 76% year-on-year but it has declined by 4.1% since the previous quarter

Dividends

What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PROK.

Financial health

How did ProKidney financials performed over time
ProKidney's total liabilities has surged by 124% YoY and by 24% QoQ
PROK's quick ratio has shrunk by 68% YoY and by 23% QoQ
ProKidney's debt is 100% more than its equity
ProKidney's debt has soared by 84% YoY and by 58% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.